| Date Filed | Type | Description |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Harshbarger Benjamin (Secretary and General Counsel) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $6.17, valued at
$277.7k
|
|
| 06/12/2020 |
3
| Harshbarger Benjamin (Secretary and General Counsel) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC |
| 05/13/2019 |
4
| Harshbarger Benjamin (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 212 shares
@ $1.22, valued at
$258.6 |
|
| 11/05/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 322 shares
@ $4.26, valued at
$1.4k
Paid exercise price by delivering 150 shares
@ $4.15, valued at
$622.5
Paid exercise price by delivering 98 shares
@ $3.94, valued at
$386.1 |
|
| 04/03/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 52 shares
@ $3.5, valued at
$182 |
|
| 02/14/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2017 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 232 shares
@ $8.97, valued at
$2.1k
Exercised 717 restricted stock units
@ $0 |
|
| 05/11/2017 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 113 shares
@ $9.42, valued at
$1.1k
Paid exercise price by delivering 121 shares
@ $9.42, valued at
$1.1k
Exercised 349 restricted stock units
@ $0
Exercised 375 restricted stock units
@ $0 |
|
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/20/2016 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 273 shares
@ $3.55, valued at
$969.2
Paid exercise price by delivering 532 shares
@ $1.78, valued at
$947
Exercised 867 restricted stock units
@ $0
Exercised 1,642 restricted stock units
@ $0 |
|
| 05/11/2016 |
4
| Harshbarger Benjamin (Acting General Counsel) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 5,100 restricted stock units
@ $0
Granted 7,300 restricted stock units
@ $0 |
|